Key terms
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PFE news
Today
1:15am ET
Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings
Yesterday
4:35pm ET
Jefferies Remains a Buy on Pfizer (PFE)
Yesterday
9:44am ET
PFE Earnings: Pfizer Rises on Smashing Q1 Estimates
Yesterday
9:05am ET
UBS Reaffirms Their Hold Rating on Pfizer (PFE)
Yesterday
9:05am ET
Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)
Yesterday
7:05am ET
Options Volatility and Implied Earnings Moves Today, May 01, 2024
Apr 30
8:25pm ET
Notable companies reporting before tomorrow’s open
Apr 30
1:39pm ET
Notable companies reporting before tomorrow’s open
Apr 30
12:45pm ET
Pfizer call volume above normal and directionally bullish
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 29
6:44pm ET
Genmab-Pfizer gain full FDA approval for TIVDAK in Metastatic Cervical Cancer
Apr 29
7:03am ET
Labcorp: FDA approves nAbCyte Anti-AAVRh74var HB-FE Assay
Apr 26
12:33pm ET
Pfizer (NYSE:PFE) Notches Up on New FDA Approval
Apr 26
6:48am ET
Pfizer announces approval of BEQVE by FDA for adults with hemophilia B
Apr 25
10:25am ET
Pfizer call volume above normal and directionally bullish
Apr 23
5:32am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)
Apr 22
8:13am ET
Pfizer announces EC approval for Emblaveo
Apr 15
2:26pm ET
Pfizer call volume above normal and directionally bullish
Apr 15
12:50pm ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
11:49am ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
11:49am ET
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Apr 15
7:40am ET
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)
Apr 15
5:48am ET
Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push
Apr 12
5:26am ET
Pfizer’s Hold Rating Upheld Amid Modest Sales Outperformance and Market Uncertainty
Apr 11
1:36pm ET
Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly
Apr 11
8:56am ET
Notable open interest changes for April 11th
Apr 08
8:56am ET
Notable open interest changes for April 8th
Apr 08
8:13am ET
ViiV Healthcare announces FDA approval of Dovato for adolescents with HIV
Apr 06
12:20am ET
Analysts’ Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)
Apr 04
7:44am ET
CCI, PFE: 2 High-Yield Dividend Stocks to Buy, According to Analysts
Apr 04
6:42am ET
Sanofi to Resolve 4,000 Zantac Cancer Lawsuits in US Courts
No recent press releases are available for PFE
PFE Financials
Key terms
Ad Feedback
PFE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PFE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
